IMF at ASH 2019

What Is Multiple Myeloma?

Multiple myeloma is a cancer of the bone marrow plasma cells. It is synonymous with "myeloma" and "plasma cell myeloma." Plasma cells make antibodies against infectious agents such as viruses and bacteria. A cancerous or malignant plasma cell is called a myeloma cell. Myeloma is called “multiple” because there are frequently multiple patches or areas in bone marrow where it grows.

ASH 2019

For more than a decade, the International Myeloma Foundation has attended the American Society of Hematology (ASH) annual meeting, an exciting convergence of more than 30,000 health-care professionals from around the world. This year’s ASH annual meeting took place in Orlando, Florida, from Dec. 7-10, 2019. Explore this page to learn about the latest blood cancer research from the meeting, especially key clinical trials to advance the treatment and management of multiple myeloma

Dr. Durie Blog

Takeaways from ASH 2019

The IMF team just returned from a busy and exciting meeting of the American Society of Hematology (ASH) in Orlando. In his post-ASH wrap-up blog, IMF Chairman Dr. Brian G.M. Durie reports on the key research takeaways. They include: a consensus on high-risk smoldering myeloma classification, excitement over the value of mass spectrometry testing, and speculation that a four-drug cocktail (a “quadruplet”) could be the new standard of care in the frontline setting.

Read Dr. Durie's blog

American Society of Hematology booth 2019

ASH 2019 Update: Late-Breaking Abstracts

ASH Top 10 for 2019: Immune therapies again dominate news

IMF Support Group Leader at ASH

IMF brings patients that are support group leaders to ASH to share their perspective.

read the blogs

Image Left

White

ASH 2019 Videos

Best of ASH 2019 Webinar

Dr. Brian G.M. Durie discusses key takeaways from the 2019 American Society of Hematology (ASH) annual conference for patients, caregivers, and others. Save the date: Thursday January 9, 2020, at 4:00 p.m. PT / 7:00 p.m. ET.

IMWG Conference Series

Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from Orlando, FL. IMF Chairman Dr. Brian G.M. Durie, Dr. Maria V. Mateos, and IMF Chief Medical Officer Dr. Joseph Mikhael distill, debate, and discuss the latest news and trends in the treatment of multiple myeloma from the 61st Annual ASH Meeting.

Approaches to Achieve the Best Possible Outcomes in Myeloma

Watch the livestream for this year’s International Myeloma Foundation and Clinical Care Options cosponsored symposium, where an esteemed panel of international experts will offer their perspectives on practice-changing data and optimal management of patients with myeloma.